Global Liver Institute Urges FDA to Approve COVID-19 Booster Vaccines for Transplant Recipients
(Washington, D.C., Monday, July 26, 2021)—Global Liver Institute (GLI) today urged the U.S. Food and Drug Administration to expedite the review of growing safety and effectiveness data and approve COVID-19 booster shots for organ transplant recipients and other immunocompromised individuals as soon as possible.
“Our population wants to be vaccinated,” Donna R. Cryer, JD, GLI CEO and president and a 26-year liver transplant recipient, wrote to Acting FDA Commissioner Janet Woodcock. “We desperately want to protect our weakened immune systems from a deadly virus and its pernicious variant. We are navigating living, working, and caring for our families, like everyone else. We, too, want to attend cook-outs and baseball games this summer. Please use your regulatory authority to help cancer, transplant, and other immunocompromised Americans safely rejoin society.”